Description: BioMark is developing proprietary, non-invasive, and accurate cancer diagnostic solutions which can help detect cancer early and cost effectively. The technology can also be used for measuring response to treatment and potentially for serial monitoring for cancer survivors.
Home Page: www.biomarkdiagnostics.com
3851 Shell Road
Richmond,
BC
V6X 2W2
Canada
Phone:
604 370 0779
Officers
| Name | Title |
|---|---|
| Mr. Rashid Ahmed Maula Bux B.Sc., MBA | Founder, CEO, Pres & Director |
| Ms. Guoyu Huang MBA | Chief Financial Officer |
| Mr. Brian Kai-Ming Cheng B.Sc., M.Sc, M.Sc. | Chief Technical Officer & Independent Director |
| Dr. Jeff Haince Ph.D. | GM & Chief Scientific Officer |
| Neal Kaplan | Chief Financial Officer of US |
| Dr. Daniel Sitar | Principal Scientific Advisor |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 105.8057 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |